- ISIN
- US85205L1070
- CUSIP
- 85205L107
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jun 5, 1987
Highlights
- Total Revenue (TTM)
- $219.67M
- Gross Profit (TTM)
- $204.80M
- EBITDA (TTM)
- -$263.55M
- Year Range
- $46.71 - $47.02
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SWTX Performance Chart
Loading charts...
Returns By Period
SpringWorks Therapeutics, Inc.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
SWTX Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.79% | 54.03% | -23.60% | 4.92% | 0.89% | 0.60% | 0.00% | 30.06% | |||||
| 2024 | 20.90% | 11.62% | -0.08% | -5.14% | -11.20% | -9.14% | -4.67% | 16.15% | -23.18% | -5.96% | 37.67% | -12.90% | -1.01% |
| 2023 | 20.72% | 1.59% | -19.31% | -9.17% | 17.11% | -4.24% | 19.68% | -10.20% | -17.96% | -0.95% | 32.71% | 20.11% | 40.33% |
| 2022 | -10.16% | 1.63% | -0.27% | -23.97% | -55.86% | 29.99% | 21.36% | -7.06% | 2.74% | -15.84% | 0.71% | 7.57% | -58.03% |
| 2021 | 14.88% | 3.29% | -14.50% | -2.32% | 13.47% | 1.07% | 3.99% | -12.37% | -15.53% | 5.71% | 7.14% | -13.74% | -14.53% |
Benchmark Metrics
SpringWorks Therapeutics, Inc. has an annualized alpha of 26.34%, beta of 1.08, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since September 16, 2019.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (61.80%) than losses (51.79%) - typical of diversified or defensive assets.
- R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 26.34%
- Beta
- 1.08
- R²
- 0.10
- Upside Capture
- 61.80%
- Downside Capture
- 51.79%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for SpringWorks Therapeutics, Inc. (SWTX) and compare them to S&P 500 Index.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the SpringWorks Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SpringWorks Therapeutics, Inc. was 80.38%, occurring on May 27, 2022. The portfolio has not yet recovered.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -80.38%May 2022 | 1y 3mo | — | 5y 3moFeb 2021 - now |
COVID crash2020 | -50.40%Mar 2020 | 12d | 2mo 25d | 3mo 7dMar 2020 - Jun 2020 |
2019 bear market2019 | -36.23%Nov 2019 | 1mo 21d | 26d | 2mo 17dSep 2019 - Dec 2019 |
2020 bear market2020 | -25.59%Jul 2020 | 24d | 2mo 7d | 3mo 1dJun 2020 - Sep 2020 |
COVID crash2020 | -22.95%Feb 2020 | 1mo 16d | 21d | 2mo 7dDec 2019 - Mar 2020 |
Drawdown Indicators
| SWTX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | -0.74% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.72% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.97% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of SpringWorks Therapeutics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how SpringWorks Therapeutics, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SWTX
Add SpringWorks Therapeutics, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SWTX